KLOW Protocol 80mg. Used to support skin health, tissue repair, recovery, inflammation control, and overall rejuvenation. Lab tested, discreetly shipped across Canada.
FormatLyophilized Vial
ConcentrationDependent on reconstitution with BAC water
Package Selected: 5 Pack Special
Pay with Interac e-Transfer or Crypto
HPLC verified. COA on file for this batch
Ships from within Canada; No Customs
Discreet plain packaging; always
24h dispatch; Tracked Delivery
The KLOW Protocol is a quad peptide blend combining GHK-Cu, BPC-157, TB-500, and KPV into a single 80mg lyophilized vial, delivering the same four compound regenerative and anti inflammatory peptide combination as the F40 Biotech KLOW Pen 145mg in a reconstitute vial format. iLab Pharma’s lyophilized vial presentation provides precise dosing flexibility and reconstitution control for researchers who prefer the adjustability of a vial based preparation over the fixed dose convenience of a prefilled pen system.
The four compound mechanism of the KLOW Protocol addresses tissue repair and inflammation modulation across four distinct but synergistic biological pathways simultaneously. GHK-Cu (Copper Tripeptide 1) drives extracellular matrix remodeling through metalloproteinase modulation and collagen and elastin synthesis stimulation, Addressing the structural tissue rebuilding phase of repair. BPC-157 promotes angiogenesis through nitric oxide pathway modulation and activates the FAK paxillin pathway driving cell migration and wound healing, providing the vascular development and growth factor signaling foundation for tissue repair. TB-500 (Thymosin Beta 4) upregulates actin polymerization and cell motility pathways, enhancing cellular migration to injury sites and supporting new blood vessel formation through a complementary angiogenic mechanism that pairs synergistically with BPC-157’s nitric oxide pathway activity. KPV: a tripeptide fragment from the C terminal sequence of alpha melanocyte stimulating hormone, contributes direct NF κB inhibition and melanocortin receptor mediated anti inflammatory activity, targeting the inflammatory component of tissue injury that the other three compounds approach primarily through structural and vascular mechanisms.
The KLOW Protocol lyophilized vial format and the F40 Biotech KLOW Pen serve the same four compound research profile across different administration format preferences; the vial offering reconstitution flexibility and precise concentration adjustment, the pen offering ready to use fixed dose convenience. CSD stocking both formats from different manufacturers gives researchers the ability to select based on protocol administration requirements while maintaining the same compound combination and research profile. Individual components are also available separately across multiple formats and concentrations throughout CSD’s full peptide range for researchers requiring custom dosing ratios or single compound sourcing.
iLab Pharma formulations are stocked by Canada Steroid Depot following the same rigorous third party lab verification process applied to every product in our range. Each batch is tested for concentration accuracy and purity across all four components before being made available, with COA documentation available on request. CSD’s sourcing standards apply uniformly across all manufacturers we carry, and iLab Pharma’s KLOW Protocol meets those standards consistently. All orders ship discreetly across Canada in plain, unmarked packaging with no identifying information on the exterior.
Reconstitute with bacteriostatic water prior to use. Store lyophilized peptide at 2–8°C away from direct light. Once reconstituted refrigerate and use within 28 days. Intended for research purposes only.
Commonly researched in tissue repair, anti inflammatory, and regenerative biology research contexts. Browse CSD’s full peptide range for complete sourcing.
KLOW Protocol 80mg is a four compound research peptide blend containing 50mg GHK-Cu, 10mg BPC-157, 10mg TB-500, and 10mg KPV in a single lyophilized vial. The formulation combines peptides associated with extracellular matrix remodeling, collagen biology, angiogenesis, cellular migration, tissue repair, epithelial integrity, and inflammatory signaling, allowing multiple regenerative research pathways to be investigated within one formulation.
KLOW is primarily associated with multi pathway research involving tissue repair, regenerative biology, extracellular matrix remodeling, collagen and elastin regulation, angiogenesis, cellular migration, inflammatory signaling, and epithelial barrier function. Each component contributes a different research pathway, making the blend useful for studying interactions between structural tissue remodeling, vascular responses, cellular repair, and inflammatory regulation.
GHK-Cu is studied for copper dependent signaling, collagen and elastin biology, extracellular matrix remodeling, and cellular regeneration. BPC-157 is investigated primarily in preclinical models involving tissue repair, angiogenesis, vascular signaling, and cellular migration. TB-500 is associated with thymosin beta 4 related research involving actin regulation, cell motility, angiogenesis, and tissue regeneration. KPV is the Lys-Pro-Val tripeptide derived from alpha MSH and is studied for anti inflammatory signaling, including pathways involving NF-kappa-B and melanocortin biology.
KLOW builds on the three compound GLOW formulation by adding KPV. GLOW combines GHK-Cu, BPC-157, and TB-500, while KLOW contains those same three research compounds plus KPV. The additional KPV component introduces a more direct inflammatory signaling research pathway alongside the extracellular matrix, angiogenesis, cellular migration, and tissue repair mechanisms already represented by the GLOW components.
Yes! This batch is HPLC tested for concentration accuracy and purity across all four components: GHK-Cu, BPC-157, TB-500, and KPV. The vial contains 80mg total peptide material. A certificate of analysis is available.
